neostem inc (NBS:NASDAQ CM)
Robin L. Smith M.D., MBA,Ro
Executive Chairman and Chief Executive Officer, Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 72 board members in 8 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Robin L. Smith, M.D., MBA, Ro, has been an Executive Chairman and Chief Executive Officer of Neostem, Inc., since June 2, 2006. Dr. Smith served as the Chairman of Advisory Board and Member of Advisory Board at Neostem, Inc., (also called as Phase III Medical Inc.) from September 21, 2005 to June 2006. She has been Senior Vice President and Chief Operating officer of Dialog Group Inc.'s Ip2M division since April 2003. She founded IP2M Inc. and served as its President ...
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships*
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee
Executive Chairman and Chief Executive Officer
University of Pennsylvania - The Wharton School
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc|
|Paul K. Wotton Ph.D.||Chief Executive Officer and President|
Advanced Cell Technology Inc.
|--||Compensation as of Fiscal Year 2013.|